Indaba Capital Management, L.P. 13D and 13G filings for Accelerate Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-06 3:10 pm Purchase |
2025-02-04 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 2,751,762 9.900% |
149,921![]() (+5.76%) |
Filing |
2024-08-12 5:01 pm Purchase |
2024-08-08 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 2,601,841 9.900% |
1,004,617![]() (+62.90%) |
Filing |
2023-06-20 5:26 pm Purchase |
2023-06-09 | 13D | Accelerate Diagnostics, Inc. AXDX |
Indaba Capital Management, L.P. | 1,597,224 9.900% |
1,597,224![]() (New Position) |
Filing |